2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members∗; Gurvitz, M; Krieger, EV; Fuller, S; Davis, LL; Kittleson, MM; Aboulhosn, JA; Bradley, EA; Buber, J; Daniels, CJ; Dimopoulos, K; Egbe, A; Geoffrion, TR; John, A; Khairy, P; Kim, YY; Kreutzer, J; Lewis, MJ; Menachem, JN; Moore, JP; Osteen, KA; Parikh, PB; Saidi, A; Salciccioli, KB; Schunder, RL; Valente, AM; Wald, RM

doi:10.1161/cir.0000000000001402

Congenital heart disease

2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

CirculationPublished 18 Dec 2025Clinical practice guideline

An erratum to this article was published (Circulation, 7 Apr 2026 ↗)

Read the original article ↗PubMed

Cite

Methodological detailsLiterature search focused on 2017 to 2024 (MEDLINE, EMBASE, Cochrane Library, AHRQ, CINAHL)

Literature search focused on 2017 to 2024 (MEDLINE, EMBASE, Cochrane Library, AHRQ, CINAHL)

Scope

As issued by the authors

Evaluation and treatment of adults with congenital heart disease; replaces the 2018 AHA/ACC guideline

Original publication

2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. Published 18 December 2025. doi:10.1161/cir.0000000000001402

Read the original article ↗

Summarised from the published abstract; every number is checked against it